Shows
PTCE Pharmacy Connect | Pharmacy TimesContinuous Glucose Monitors in Diabetes Management | PTCE Pharmacy ConnectContinuous Glucose Monitoring:Understanding the Pharmacist’s Role in Patient Education and Improving Outcomes in Diabetes Management
Objectives
Describe the use of continuous glucose monitoring (CGM) in diabetes management and ADA/AACE recommendations
Recognize the role of the pharmacist in providing education related to the use of CGM devices and interpreting CGM data
Faculty Disclosures
Curtis L. Triplitt, PharmD, has the following relevant financial relationships with commercial interests to disclose:
Consultant: Bayer
Speaker’s Bureau: Eli Lilly, NovoNordisk
Susan Cornell, PharmD, CDCES, FAPhA, FADCES, has the following relevant financial relationships with commercial interests to disclose:
Speaker’s Bureau: Novo Nordisk, Inc.
Othe...2021-04-3025 min
PTCE Pharmacy Connect | Pharmacy TimesContinuous Glucose Monitors in Diabetes Management | PTCE Pharmacy ConnectContinuous Glucose Monitoring:Understanding the Pharmacist’s Role in Patient Education and Improving Outcomes in Diabetes Management
Objectives
Describe the use of continuous glucose monitoring (CGM) in diabetes management and ADA/AACE recommendations
Recognize the role of the pharmacist in providing education related to the use of CGM devices and interpreting CGM data
Faculty Disclosures
Curtis L. Triplitt, PharmD, has the following relevant financial relationships with commercial interests to disclose:
Consultant: Bayer
Speaker’s Bureau: Eli Lilly, NovoNordisk
Susan Cornell, PharmD, CDCES, FAPhA, FADCES, has the following relevant financial relationships with commercial interests to disclose:
Speaker’s Bureau: Novo Nordisk, Inc.
Othe...2021-04-3025 min
ASHP Advantage's Engaging the ExpertsIndividualizing Insulin Therapy for Type 2 Diabetes Mellitus (Part 2 of 2)Part 2: Future Treatment Options and Roles for Pharmacists in Individualizing Insulin Therapy
In Part 2 of this two-part “Engaging the Experts” interview, William Zellmer talks with Curtis L. Triplitt, Susan Cornell, and Joshua J. Neumiller regarding future treatment options for type 2 diabetes and the roles for pharmacists in individualizing insulin therapy. This installment is produced by ASHP Advantage and supported by Novo Nordisk Inc.
Faculty:
Curtis Triplitt, PharmD, CDE
Associate Director, Diabetes Research Center, Texas Diabetes Institute
Associate Professor, Department of Medicine, Division of Diabetes
University of Texas Health Science Cent...2017-02-2826 minASHP Advantage's Engaging the ExpertsIndividualizing Insulin Therapy for Type 2 Diabetes Mellitus (Part 1 of 2)Part 1: Barriers to Optimizing the Use of Insulin in Managing Type 2 Diabetes
In Part 1 of this two-part “Engaging the Experts” interview, William Zellmer talks with Curtis L. Triplitt, Susan Cornell, and Joshua J. Neumiller regarding the barriers to optimizing the use of insulin in managing patients with type 2 diabetes. This installment is produced by ASHP Advantage and supported by Novo Nordisk Inc.
Faculty:
Curtis Triplitt, PharmD, CDE
Associate Director, Diabetes Research Center, Texas Diabetes Institute
Associate Professor, Department of Medicine, Division of Diabetes
University of Texas Health Science Center at S...2017-02-2821 minASHP Advantage's Engaging the ExpertsFocus on SGLT2 inhibitors for Diabetes Part 2 of 2William Zellmer talks with Susan Cornell and Curtis Triplitt about SGLT2 inhibitors, one of the newest classes of oral diabetes medications. With an increasing number of both oral and injectable medications, the faculty explore how SGLT2 inhibitors fit into clinical practice.
Faculty:
Susan Cornell, Pharm.D., CDE, FAPhA, FAADE, Activity Chair
Assistant Director of Experiential Education
Associate Professor
Department of Pharmacy Practice
Midwestern University Chicago College of Pharmacy
Downers Grove, Illinois
Curtis L. Triplitt, Pharm.D., CDE
Associate Director, Diabetes Research Center, Texas Diabetes Institute
...2015-03-0309 minASHP Advantage's Engaging the ExpertsFocus on SGLT2 inhibitors for Diabetes Part 1 of 2William Zellmer talks with Susan Cornell and Curtis Triplitt about SGLT2 inhibitors, one of the newest classes of oral diabetes medications. With an increasing number of both oral and injectable medications, the faculty explore how SGLT2 inhibitors fit into clinical practice.
Faculty:
Susan Cornell, Pharm.D., CDE, FAPhA, FAADE, Activity Chair
Assistant Director of Experiential Education
Associate Professor
Department of Pharmacy Practice
Midwestern University Chicago College of Pharmacy
Downers Grove, Illinois
Curtis L. Triplitt, Pharm.D., CDE
Associate Director, Diabetes Research Center, Texas Diabetes Institute
...2015-03-0307 min